Sign In
Buy CLVS
$0.151
+0 (+0%)
At Close: Apr 19, 2023
Why Clovis Oncology Stock Skyrocketed 80% This Week
08:41pm, Thursday, 31'st Mar 2022 The Motley Fool
Positive data regarding its lead drug boosted the company's shares.
Clovis Oncology: Forging A Fresh Perspective
07:23pm, Thursday, 31'st Mar 2022
Clovis Oncology recently reported impressive data from their ATHENA-MONO Phase III study. The ATHENA-MONO data should support the use of Rubraca in the first-line ovarian setting.
Why Clovis Oncology Stock Skyrocketed 80% This Week
04:41pm, Thursday, 31'st Mar 2022
Positive data regarding its lead drug boosted the company's shares.
Trading Penny Stocks? Top Stock Market News for March 31st, 2022
01:25pm, Thursday, 31'st Mar 2022 PennyStocks
Here's what you need to know about trading penny stocks on March 31st
The post Trading Penny Stocks? Top Stock Market News for March 31st, 2022 appeared first on Penny Stocks to Buy, Picks, News and I
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
12:14pm, Thursday, 31'st Mar 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Amylyx Says FDA Committee Casts Negative Vote On ALS Drug
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX)
Clovis Oncology News: Why CLVS Stock Is Roaring Higher Today
11:23am, Thursday, 31'st Mar 2022
Clovis Oncology (CLVS) stock is in the news Thursday as shares rocket higher thanks to positive data from a recent clinical trial. The post Clovis Oncology News: Why CLVS Stock Is Roaring Higher Today
Clovis Oncology's Rubraca Significantly Improves PFS In Ovarian Cancer Regardless Of Biomarker Status
09:34am, Thursday, 31'st Mar 2022
Clovis Oncology Inc (NASDAQ: CLVS) announced positive topline data from the monotherapy arm of Phase 3 ATHENA-MONO trial of Rubraca (Rucaparib) as first-line maintenance treatment in ovarian cancer
Trading Penny Stocks? Top Stock Market News for March 31st, 2022
09:25am, Thursday, 31'st Mar 2022
Here's what you need to know about trading penny stocks on March 31st The post Trading Penny Stocks? Top Stock Market News for March 31st, 2022 appeared first on Penny Stocks to Buy, Picks, News and I
Why Clovis Oncology Stock Is Soaring Today
09:18am, Thursday, 31'st Mar 2022
Clovis Oncology Inc (NASDAQ: CLVS) is trading higher Thursday morning after the company announced data from the monotherapy arm of the ATHENA trial achieved the primary endpoint of significantly impr
Clovis Oncology to seek FDA approval for ovarian cancer drug as a maintenance therapy
08:01am, Thursday, 31'st Mar 2022
Shares of Clovis Oncology Inc. CLVS, -3.51% soared 40.0% in premarket trading on Thursday after the company said its drug, Rubraca, improved survival when used as a maintenance treatment for women wit
Why Is Clovis (CLVS) Down 14.8% Since Last Earnings Report?
03:30pm, Friday, 25'th Mar 2022 Zacks Investment Research
Clovis (CLVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Clovis (CLVS) Down 14.8% Since Last Earnings Report?
01:32pm, Friday, 25'th Mar 2022
Clovis (CLVS) reported earnings 30 days ago. What's next for the stock?
AstraZeneca, Merck's Lynparza Cut Risk of Breast Cancer Death
05:15pm, Thursday, 17'th Mar 2022 Zacks Investment Research
Treatment with AstraZeneca (AZN) and Merck's (MRK) Lynparza show meaningful improvement in overall survival for patients with BRCA-mutated HER2-negative high-risk early breast cancer.
AstraZeneca, Merck's Lynparza Gets FDA Nod for Expanded Use
02:34pm, Monday, 14'th Mar 2022 Zacks Investment Research
FDA approves AstraZeneca (AZN) and Merck's (MRK) Lynparza for BRCA-mutated HER2-negative high-risk early breast cancer.
Hot Penny Stocks to Watch Next Week? 3 For Your List
12:30pm, Saturday, 12'th Mar 2022
Which penny stocks are on your watchlist for next week? The post Hot Penny Stocks to Watch Next Week?
